Table 2.

Adverse drug reactions in the safety analysis set (n = 186)

Adverse drug reactiona,b	Patients, n (%)	Incidence (patient-yearsc = 438.8)
Increased blood creatine phosphokinase	4 (2.2)	11.4
Impaired glucose tolerance	2 (1.1)	4.56
Craniopharyngioma	1 (0.5)	2.28
Drug administration error	1 (0.5)	2.28
Exostosis	1 (0.5)	2.28
Gait disturbance	1 (0.5)	2.28
Headache	1 (0.5)	2.28
Hyperinsulinism	1 (0.5)	2.28
Increased insulin-like growth factor	1 (0.5)	2.28
Metabolic disorder	1 (0.5)	2.28
Sleep apnoea syndrome	1 (0.5)	2.28
Snoring	1 (0.5)	2.28

^aPreferred term/MedDRA dictionary

^bMild or moderate

^cUntil cut-off date